Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Laboratory Corp American Holdings (NY:LH)

242.53 +0.64 (+0.26%)
Official Closing Price Updated: 4:10 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Laboratory Corp American Holdings

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records. 
Via Talk Markets
2 aerospace stocks are ready to take flight on the next leg up
The aerospace sector has been red hot in 2023; here are two surging aerospace stocks with the potential to reach even higher altitudes 
Via MarketBeat
SLB, Marvell Technology And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by over 1% on Monday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
7 Analysts Have This to Say About Laboratory Corp
Via Benzinga
Why Fortrea Holdings Shares Are Gaining Today
Activist hedge fund Starboard Value holds a  
Via Benzinga
Bear Of The Day: Labcorp
Analysts have slashed their earnings expectations for the company, pushing it down to a Zacks Rank #5 (Strong Sell). 
Via Talk Markets
Expert Ratings for Laboratory Corp
Via Benzinga
Where Laboratory Corp Stands With Analysts
Via Benzinga
Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today
The company's first quarter as a separate entity was better than anticipated. 
Via The Motley Fool
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
Blood tests for diagnosing Alzheimer's disease are eagerly awaited, but it may be a couple of years before they become a routine diagnostic tool. While several blood tests for Alzheimer's diagnosis are... 
Via Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
Exposures COVID-19
Expert Ratings for Laboratory Corp
Via Benzinga
Why Shares of Labcorp Dropped Monday
The company completed the spinoff of contract research organization Fortrea Holdings. 
Via The Motley Fool
Analyst Ratings for Laboratory Corp
Via Benzinga
Labcorp's Q1 Revenue Falls On Decline In COVID-19 Testing Sales
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
Via Benzinga
The 7 Most Undervalued Value Stocks to Buy Now: August 2023
While it’s difficult to ignore the hot flavors of the week, investors should target these undervalued value stocks for the best bargains. 
Via InvestorPlace
Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Earnings Outlook For Laboratory Corp
Via Benzinga
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
From Enzo Biochem, Inc.
Via GlobeNewswire
Visualizing The Entire S&P 500
One of the biggest challenges market analysts have is how to visualize the companies that make up the S&P 500. 
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster
From Fortrea Holdings Inc
Via GlobeNewswire
FDA Readies Proposal for Increased Oversight on Lab-developed Tests
The FDA is preparing to increase regulation of a widely used class of tests conducted by laboratories to detect cancer, measure cholesterol, and identify other health issues. The FDA is developing a... 
Via Benzinga
3 No-Brainer Stocks to Buy in a Correction
Stock market downturns present great opportunities to go shopping for wonderful stocks. 
Via The Motley Fool
Exact Sciences Serves Investors Exactly What They Wished For
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The 
Via MarketBeat
3 Telemedicine Stocks to Watch as Healthcare Goes Digital
The telemedicine stocks discussed in the article offer incredible upside ahead in the fast-evolving telehealth sector 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.